Pharmaceutical News

RSS

Bariatric surgery outperforms GLP-1 medications in protecting kidney function

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery was associated with a significant decrease in the progression of chronic kidney disease compared to those who received GLP-1 diabetes medications. The paper was published in Annals of Surgery.

20 Sep 2024

Promising antidepressant offers hope for glioblastoma treatment

Glioblastoma is a particularly aggressive brain tumor that at present is incurable. Cancer doctors can extend patients' life expectancy through operations, radiation, chemotherapy or surgical interventions. Nevertheless, half of patients die within twelve months of diagnosis.

20 Sep 2024

FUJIFILM Irvine Scientific develops Oceo Rover: The first automated single-use hydration system for media and buffers

FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, today announced the development of Oceo Rover, a first-of-its-kind* single-use technology system, that enables manufacturers of biopharmaceuticals to improve bioprocessing workflows by automating and simplifying the hydration of media, feeds, and buffers.

From FUJIFILM Irvine Scientific 20 Sep 2024

Triptans prove to be more effective for acute migraines than newer drugs

Some triptans are a more effective treatment for acute migraines than newer, more expensive drugs, finds an analysis of the latest evidence published by The BMJ today.

18 Sep 2024

Study links diabetes drugs to lower risk of dementia and Parkinson's disease

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

18 Sep 2024

Antibiotic resistance threatens millions of lives worldwide

More than 39 million people around the world could die from antibiotic-resistant infections over the next 25 years, according to a study published in The Lancet.

18 Sep 2024

Low-dose ketamine eases fentanyl withdrawal symptoms

Drug overdose is the leading cause of injury deaths in young adults in the United States, with fentanyl causing over 70,000 deaths annually.

17 Sep 2024

Semaglutide vs. liraglutide: One-year weight loss efficacy in obesity and type 2 diabetes

Researchers compare the weight loss efficacy of injectable liraglutide and semaglutide.

17 Sep 2024

Cognitive distortions and deliberate ignorance lead to COVID-19 vaccine refusal, study says

Researchers find that deliberate ignorance and cognitive distortions drive COVID-19 vaccine refusal, emphasizing the need for tailored communication strategies.

17 Sep 2024

Study highlights limited evidence for antidepressants in treating pain in older adults

University of Sydney research has found people over 65 are being prescribed antidepressants as pain treatment based on international guidelines that use limited evidence.

16 Sep 2024

Single dose of MVA-BN vaccine offers 58% protection against mpox

Researchers confirm the effectiveness of the modified vaccinia Ankara-Bavarian Nordic vaccine against mpox.

16 Sep 2024

Cardiovascular risks of COVID-19 antivirals

Study reviews cardiovascular side effects linked to antiviral therapies for COVID-19, highlighting the need for careful consideration when prescribing these drugs to high-risk patients.

16 Sep 2024

Evolution of vaccine adjuvants from empirical discovery to rational design

Vaccine adjuvants have evolved significantly since their inception, transitioning from empirical discovery to a more structured approach grounded in rational drug design.

13 Sep 2024

Study sheds light on potential demand for psilocybin-assisted therapy for depression in the U.S.

In the wake of mounting evidence for the efficacy of psychedelic-assisted therapies, the U.S. Food and Drug Administration (FDA) is considering approving psilocybin, the active ingredient in "magic mushrooms," for treating depression in the near future.

13 Sep 2024

GLP-2 regulates appetite by influencing gut-brain communication and gastrointestinal motility

Researchers examine the role of GLP-2 in regulating food intake through its effects on gastrointestinal motility and satiety signals, offering insights into potential obesity treatments.

12 Sep 2024

COVID-19 vaccines prevented millions of deaths across Latin America and the Caribbean, study shows

Researchers estimate that COVID-19 vaccines averted between 610,000 and 2.62 million deaths in select Latin American and Caribbean countries from early 2021 to May 2022.

12 Sep 2024

Pharma companies' strategies for reaching poorer countries remain unclear

Pharmaceutical companies must prioritize efforts to reach patients in underserved parts of the world with medicines such as insulin for diabetics and, crucially, measure the effectiveness of these efforts, says Jayasree Iyer, CEO of the Access to Medicine Foundation.

12 Sep 2024

New IndiPHARM initiative aims to revolutionize personalized medication management

A Columbia University-led multicenter research effort called IndiPHARM: individual metabolome and exposome assessment for pharmaceutical optimization will develop a platform and monitoring system to prevent unwanted interactions between medications and other environmental, genetic, and lifestyle factors, in order to optimize therapeutic efficacy.

12 Sep 2024

Molnupiravir reduces long-term COVID-19 symptoms but shows limited impact on hospitalizations

Molnupiravir treatment for COVID-19 shows modest long-term benefits, reducing symptoms and improving well-being at three and six months. However, the differences were small, with no impact on hospitalization rates.

11 Sep 2024

Ropirio Therapeutics secures exclusive license for novel lymphatic system activators

The Wyss Institute at Harvard University announced today that Ropirio Therapeutics, Inc. (Ropirio) has secured a worldwide, exclusive license from Harvard's Office of Technology Development (OTD) and Boston University (BU)'s Technology Development office for novel molecules that activate the lymphatic system - a first in the pharma industry.

11 Sep 2024

Previous
1
...
4
5
6
7
8
9
10
...
1433
Next

Pharmaceutical News

Bariatric surgery outperforms GLP-1 medications in protecting kidney function

Promising antidepressant offers hope for glioblastoma treatment

FUJIFILM Irvine Scientific develops Oceo Rover: The first automated single-use hydration system for media and buffers

Triptans prove to be more effective for acute migraines than newer drugs

Study links diabetes drugs to lower risk of dementia and Parkinson's disease

Antibiotic resistance threatens millions of lives worldwide

Low-dose ketamine eases fentanyl withdrawal symptoms

Semaglutide vs. liraglutide: One-year weight loss efficacy in obesity and type 2 diabetes

Cognitive distortions and deliberate ignorance lead to COVID-19 vaccine refusal, study says

Study highlights limited evidence for antidepressants in treating pain in older adults

Single dose of MVA-BN vaccine offers 58% protection against mpox

Cardiovascular risks of COVID-19 antivirals

Evolution of vaccine adjuvants from empirical discovery to rational design

Study sheds light on potential demand for psilocybin-assisted therapy for depression in the U.S.

GLP-2 regulates appetite by influencing gut-brain communication and gastrointestinal motility

COVID-19 vaccines prevented millions of deaths across Latin America and the Caribbean, study shows

Pharma companies' strategies for reaching poorer countries remain unclear

New IndiPHARM initiative aims to revolutionize personalized medication management

Molnupiravir reduces long-term COVID-19 symptoms but shows limited impact on hospitalizations

Ropirio Therapeutics secures exclusive license for novel lymphatic system activators

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News